SIRT2 and Parkinson disease: Some evidence suggests that SIRT2 is an emerging target in controlling PD by participating in the processes of PD pathogenesis, including the aggregation of α-syn, inflammation, oxidative stress, autophagy, and microtubule function (Singh et al., 2021).